Latest News
Subscribe to our latest news feed
A group of 40 global investors have become the first to
sign the Principles for Investors in Inclusive Finance. The principles have been formally
launched today at the Responsible Finance Forum, hosted by the Dutch Ministry of
Foreign Affairs in The Hague, the Netherlands.
Read More
The Small Enterprise Impact Investment Fund (SEIIF) is a joint initiative between Oxfam and asset management group, Symbiotics. The first fund of its kind, the SEIIF will target small and medium enterprises (SMEs) in developing countries, offering investors both measurable social impacts and financial returns, with relatively low risk.
Read More
Switzerland, a Global Market Leader in Microfinance Investments –
Symbiotics and the Swiss Agency for Development and Cooperation (“SDC”) Co-Fund Study on Swiss Microfinance Investments
Read MoreEn FrançaisAuf Deutsch
Symbiotics together with REGMIFA, the Regional MSME Investment Fund for Sub-Saharan Africa SA, SICAV-SIF, sponsored the Hanson Wade event: Investment & Innovation in Microfinance in Africa which took place in Nairobi on October 17th to 19th. It was a true success with an attendance of over 150 microfinance investors including strong informative speeches and panel discussions inviting the audience to debate the African market issues.
Read More
Symbiotics SA, the Geneva-based microfinance investment services company, is pleased to announce that it has attained the one billion dollar mark in loan disbursement. After six years of operation and with a dedicated staff of 40 and 4 offices worldwide, this once pioneer company has reached this milestone through strong and many long-standing partnerships with 25 MIVs helping over 400,000 unbanked people through 167 MFIs to gain access to capital in 41 emerging countries.
Symbiotics adds to its achievements a consistently high number of loans disbursed, currently representing 1022, with an average total loan disbursement of USD 14,000,000 per month.
Read More
Symbiotics Research & Advisory SA is pleased to announce the release of the Symbiotics 2011 MIV Survey. The Survey provides key data and benchmarks of 70 MIVs, covering 87% of the MIV market, currently estimated at USD 6.8 billion.
Read More
During the Symbiotics’ annual General Assembly held in Geneva in late June, Ivan Pictet was elected unanimously to become a member of the Board of Directors after having followed the company since its launch in 2005.
Read More
Symbiotics Research & Advisory reporting and analysis tools now available on-line at syminvest.com to all microfinance investors and fund managers.
Industry, Markets, Funds and Institutions modules have been developed to respond to increasing research and analysis needs as a consequence of the global financial crisis as well as the general growth and sophistication of the microfinance investments marketplace.
Read More
Symbiotics, a leading microfinance investment services company, launched on Thursday December 16th Micro, Small & Medium Enterprise Bonds SA (MSME Bonds), an issuance platform based in Luxembourg dedicated to impact investing for institutional investors.
Read More
Symbiotics Asset Management SA has been selected as Fund Manager of the first Regional Investment Fund for Micro, Small and Medium Enterprises in Sub‐Saharan Africa (REGMIFA).
Read MoreEn FrançaisAuf Deutsch